What is Ardelyx's business segments — selling?

Ardelyx (ARDX) reported business segments — selling of $67.4M in Q1 2026.

What does business segments — selling mean?

Captures the expenses incurred to market, promote, and distribute the company's pharmaceutical products to healthcare providers and patients. These costs are essential for driving product awareness and market penetration in competitive therapeutic areas. Monitoring this helps assess the efficiency of the company's commercial infrastructure.

Ardelyx ARDX Business Segments — Selling

Similar metrics at other companies

SUPNReportable Segment — Selling expenses

$66.28M+55.5%

TARSReportable Segment — Sales & Marketing

$84.48M+40.1%

PEGAReportable Segment — Selling

$133.14M+11.8%

GILDReportable Segment — Selling and marketing expenses

$898M+19.3%

ARH

ARHSReportable Segment — Selling expenses

$44.65M+0.6%

INCYReportable Segment — Sales and marketing

$259.56M+0.7%

Other financials

Income statement

See full

Revenue$94.5M+27.5%

Gross profit$89.7M+45.1%

Operating income-$32.8M+9.8%

Net income-$37.6M+8.6%

EPS (diluted)-$0.15+11.8%

Balance sheet

See full

Cash & equivalents$31.2M+1.3%

Total debt$208.3M+34.3%

Total equity$148.6M+2.0%

Total assets$504.5M+23.0%

Cash flow

See full

Operating cash flow-$32.2M+16.2%

CapEx$69.0K-78.8%

Free cash flow-$32.3M+16.7%

Valuation

See full

Market cap$1.53B+79.5%

Enterprise value$1.71B+74.8%

P/S3.6×+1.2×

Profitability

See full

Gross margin92.5%+7.9pp

Operating margin-25.4%—

Net margin-13.6%—

FCF margin-40.9%—

Returns & leverage

See full

Return on equity-39.5%—

Debt / equity1.4×+0.3×

Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept ardx:SellingExpenseAdjusted.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's business segments — selling.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardelyx's business segments — selling?: Ardelyx (ARDX) reported business segments — selling of $67.4M in Q1 2026.
What does business segments — selling mean?: Captures the expenses incurred to market, promote, and distribute the company's pharmaceutical products to healthcare providers and patients. These costs are essential for driving product awareness and market penetration in competitive therapeutic areas. Monitoring this helps assess the efficiency of the company's commercial infrastructure.